Brief: Enveric Biosciences Receives Notice Of Allowance For New Class Of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders
10/06/2025 15:22
June 10 (Reuters) - Enveric Biosciences Inc ENVB.O: ENVERIC BIOSCIENCES INC: RECEIVES NOTICE OF ALLOWANCE FOR NEW CLASS OF LOW-HALLUCINOGENIC NEUROPLASTOGENS TARGETING PSYCHIATRIC DISORDERS Source text: ID:nBw7drwHra Further company coverage: ENVB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003